OCUP Ocuphire Pharma Inc
19,289
$1.69
$0.05
(2.88%)
| Watchers | 19,289 |
| 52-Wk Low | $1.50 |
| 52-Wk High | $4.58 |
| Market Cap | $43.68M |
| Volume | 114,524.00 |
| 52-Wk High | $4.58 |
| 52-Wk Low | $1.50 |
Ocuphire Pharma announces U.S. commercial launch of RYZUMVIThe Fly • about 2 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment...
Ocuphire Pharma, Inc. (NASDAQ:OCUP Get Free Report) CFO Nirav S. Jhaveri acquired 10,000 shares of Ocuphire Pharma stock in a transaction dated Thursday, March 21st. The stock was purchased...
Ocuphire Pharma, Inc. (NASDAQ:OCUP Get Free Report) CEO George Magrath acquired 25,000 shares of the firms stock in a transaction on Monday, March 18th. The stock was purchased at an...
FARMINGTON HILLS, Mich., March 08, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule...
FARMINGTON HILLS, Mich., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) ( Ocuphire ), a clinical-stage ophthalmic biopharmaceutical company focused on developing and...
FARMINGTON HILLS, Mich., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial Officer FARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE...
FARMINGTON HILLS, Mich., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing...